Keywords: amgen, bdnf, fails, clinical, trials, als, regeneron

Amgen's BDNF Fails In Clinical Trials For ALS

Article | 20 January 1997

Amgen and Regeneron Pharmaceuticals' brain-derived neurotrophic factor,which was in Phase III clinical trials for the treatment of the neurodegenerative ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amgen

Go to company listing

Related Drugs

Filgrastim

Neupogen

Go to drug listing